刊物主题:Infectious Diseases; Parasitology; Medical Microbiology; Tropical Medicine; Internal Medicine;
出版者:BioMed Central
ISSN:1471-2334
文摘
Background Hepatitis B is a major health concern in Africa. The vaccine against hepatitis B virus (HBV) was introduced into the Expanded Programme on Immunization (EPI) of Cameroon and Senegal in 2005, and of CAR (Central African Republic) in 2008. A cross-sectional study was conducted to assess HBV immunization coverage following the vaccine’s introduction into the EPI and factors associated with having been vaccinated.